Drug delivery systems for overcoming the bioavailability of curcumin: Not only the nanoparticle matters

Nanomedicine

Volumn 9, Issue 6, 2014, Pages 747-750

  Peng, Jin Rong ^a   Qian, Zhi Yong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

anticancer; bioavailability; drug delivery system; drug targeting; hydrogel nanoparticle composites; nanomedicine; tissue engineering

Indexed keywords

CURCUMIN; DENDRIMER; LIPOSOME; NANOCARRIER; NANOCRYSTAL; NANOFIBER; NANOPARTICLE; POLYAMIDOAMINE; POLYCAPROLACTONE; POLYMER; ANTINEOPLASTIC AGENT; DRUG CARRIER;

CANCER INHIBITION; CHEMICAL MODIFICATION; CIRCULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HYDROGEL; IMPLANT; MICELLE; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; BIOAVAILABILITY; CHEMISTRY;

ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CURCUMIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES;

EID: 84903768999     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.21     Document Type: Review

References (20)

1. Esatbeyoglu T, Huebbe P, Ernst IMA et al. Curcumin - from molecule to biological function. Angew. Chem. Int. Ed. 51, 5308-5332 (2012).
2. Ireson C, Orr S, Jones DJ et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61, 1058-1064 (2001). (Pubitemid 32174425)
3. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 16(3), 259-265 (1980). (Pubitemid 10056763)
4. Cheng AL, Hsu CH, Lin JK et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21(4B), 2895-2900 (2001).
5. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27, 486 (1999).
6. Sun M, Su X, Ding B et al. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine (Lond.) 7(7), 1085-1100 (2012).
7. Qian ZY, Fu SZ, Feng SS. Nanohydrogels as a prospective member of the nanomedicine family. Nanomedicine (Lond.) 8(2), 161-164 (2013).
8. Peng JR, Qi TT, Liao JF et al. Controlled release of cisplatin from pH-thermal dual responsive nanogels. Biomaterials 34, 8726-8740 (2013).
9. Shi W, Dolai S, Rizk S et al. Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Org. Lett. 9(26), 5461-5464 (2007).
10. Li J, Wang Y, Yang C et al. PEGylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol. Pharmacol. 76(1), 81-90 (2009).
11. Tang HD, Murphy CJ, Zhang B et al. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine (Lond.) 5(6), 855-865 (2010).
12. Gou ML, Men K, Shi HS et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558-1567 (2011).
13. Gong CY, Deng SY, Wu QJ et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34, 1413-1432 (2013).
14. Guo G, Fu SZ, Zhou LX et al. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε- caprolactone) nanofibers and their in vitro antitumor activity against glioma 9L cells. Nanoscale 3, 3825-3832 (2011).
15. Fu SZ, Ni PY, Wang BY et al. Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collegen/n-HA hydrogel composite for guided bone regeneration. Biomaterials 33(19), 4801-4809 (2012).
16. Fang F, Gong CY, Qian ZY et al. Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano 3(12), 4080-4088 (2009).
17. Gong CY, Wu QJ, Wang YJ et al. A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials 34, 6377-6387 (2013).
18. Peer D, Karp JM, Hong S et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007). (Pubitemid 350223348)
19. Schroeder A, Heller DA, Winslow MM et al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12, 39-50 (2012).
20. Gong CY, Qi TT, Wei XW et al. Thermosensitive polymeric hydrogels as drug delivery systems. Curr. Med. Chem. 20(1), 79-94 (2013).